Both PARP inhibitors receive positive opinions from CHMP

Swiss pharma company to acquire biotech for $449m (€380m)

Data presented at 2020 ESMO virtual congress

Viral vector manufacturer Vibalogics adds CEO to lead expansion, COVID-19 response kblankenship Mon, 09/21/2020 – 19:14

Updated Date: Mon, 14 Sep 2020 00:00:00 EDT

Updated Date: Mon, 14 Sep 2020 00:00:00 EDT

Holst and colleagues discuss the asthma risk to children of being exposed to fine particular matter (PM2.5).1 Their […]

ESMO: Merck’s Keytruda pushes for 2nd esophageal cancer nod with first-line survival win chelfand Mon, 09/21/2020 – 12:25

ESMO: Roche, after Tecentriq’s ovarian cancer fail, banks hopes on final survival analysis aliu Sun, 09/20/2020 – 07:45

ESMO: Merck’s Keytruda doubles 5-year survival rate for lung cancer patients chelfand Mon, 09/21/2020 – 02:00